Skip to main content
Log in

IL-22: A critical mediator in mucosal host defense

  • Review
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

IL-22 is an IL-10 family cytokine member that was recently discovered to be produced by Th17 cells. Current studies have revealed that IL-22 targets cells of the digestive, skin, and respiratory organ systems and plays an important role in mucosal immunity. The IL-22 receptor (IL-22R) is expressed exclusively in these tissues, thereby allowing the cytokine to mediate epithelial innate immunity in response to a variety of pathogens. Although recent studies have shown the importance of IL-22 in host defense against Gram-negative bacterial organisms (in gut and lung), there is evidence that IL-22 also plays a role in autoimmune disease, such as psoriasis. IL-22 therefore, not unlike other cytokines, has complex pro-inflammatory, anti-inflammatory, and autoimmune effects which continue to be under further investigation. This review will focus on what is known about IL-22 and its function in mucosal host defense.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Dumoutier et al (2000) Cloning and characterization of IL-10-related T cell derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164:1814–1819

    CAS  PubMed  Google Scholar 

  2. Wolk K, Sabat R (2006) Interleukin-22: a novel T and NK cell-derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17:367–380

    Article  CAS  PubMed  Google Scholar 

  3. Wolk X et al (2004) IL-22 increases the innate immunity of tissues. Immun 21:241–254

    Article  CAS  Google Scholar 

  4. Wynn T (2005) Th17: a giant step from Th1 and Th2. Nat Immunol 6:1069–1070

    Article  CAS  PubMed  Google Scholar 

  5. Betteli X et al (2007) Th17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345–350

    Article  Google Scholar 

  6. Liang X et al (2006) Interleukin 22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279

    Article  CAS  PubMed  Google Scholar 

  7. Boniface X et al (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174:3695–3702

    CAS  PubMed  Google Scholar 

  8. Wolk X et al (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309–1323

    Article  CAS  PubMed  Google Scholar 

  9. Ma X et al (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597–607

    CAS  PubMed  Google Scholar 

  10. Caproni X et al (2008) Serum levels of IL-17 and IL-22 are reduced by Etanercept, but not by Acitretin, in patients with psoriasis: a randomized controlled trial. J Clin Immunol. doi:10.1007/s10875-008-9233-0

  11. Nagalakshmi X et al (2004) Interleukin 22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 4:679–691

    Article  CAS  PubMed  Google Scholar 

  12. Brand X et al (2006) IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290:G827–G838

    Article  CAS  PubMed  Google Scholar 

  13. Sugimoto X et al (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:534–544

    CAS  PubMed  Google Scholar 

  14. Zheng X et al (2008) Interleukin 22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282–289

    Article  CAS  PubMed  Google Scholar 

  15. Whittington X et al (2004) IL-22: a potential immunomodulatory molecule in the lung. Am J Respir Cell Mol Biol 31:220–226

    Article  CAS  PubMed  Google Scholar 

  16. Aujla X et al (2008) IL-22 mediates mucosal host defense against gram negative bacterial pneumonia. Nat Med 14:275–281

    Article  CAS  PubMed  Google Scholar 

  17. Andoh X et al (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterol 129:969–984

    Article  CAS  Google Scholar 

  18. Cella X et al (2008) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nat: Epub ahead of print

  19. Wolk X et al (2007) IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn’s disease. J Immunol 178:5973–5981

    CAS  PubMed  Google Scholar 

  20. Zheng X et al (2007) Interleukin-22, a Th17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nat 445:648–651

    Article  CAS  Google Scholar 

  21. Malmberg K, Ljunggren H (2009) Spotlight on IL-22-producing NK cell receptor expressing mucosal lymphocytes. Nat Immunol 10:11–12

    Article  CAS  PubMed  Google Scholar 

  22. Sanos X et al (2009) RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10:83–91

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. J. Aujla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aujla, S.J., Kolls, J.K. IL-22: A critical mediator in mucosal host defense. J Mol Med 87, 451–454 (2009). https://doi.org/10.1007/s00109-009-0448-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-009-0448-1

Keywords

Navigation